SHANDONG BOAN BIOTECH.H 1 Cash Flow Quality Index
SHANDONG BOAN BIOTECH.H 1 cash flow quality index. SHANDONG BOAN BIOTECH.H 1 (UJ9) has a Cash Flow Quality Index of 9.08x as of December 2025. Operating cash flow of €64.89 Million exceeds net income of €7.14 Million, indicating high earnings quality where cash backs reported profits. See UJ9 free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Cash Flow Quality Index
Operating Cash Flow
Net Income
Data as of
Cash Flow Quality Index of SHANDONG BOAN BIOTECH.H 1 (2024–2025)
Cash flow quality index of SHANDONG BOAN BIOTECH.H 1 from 2024 to 2025. Historical Cash Flow Quality Index for SHANDONG BOAN BIOTECH.H 1 across 2 annual periods. Values consistently above 1.0x indicate high-quality earnings. Explore cash flow to debt ratio of SHANDONG BOAN BIOTECH.H 1 to assess how comfortably operating cash covers total debt obligations.
SHANDONG BOAN BIOTECH.H 1 Cash Flow Quality Index by Year (2024–2025)
SHANDONG BOAN BIOTECH.H 1 cash flow quality index by year from 2024 to 2025. Year-by-year earnings quality comparison for SHANDONG BOAN BIOTECH.H 1. For the full cash flow conversion analysis, see SHANDONG BOAN BIOTECH.H 1 (UJ9) cash conversion ratio.
| Year | Quality Index | Operating CF (EUR) | Net Income | YoY Change |
|---|---|---|---|---|
| 2025 | 9.08x | €64.89 Million | €7.14 Million | ▲ +663.7% |
| 2024 | -1.61x | €-117.94 Million | €73.19 Million | — |